[1]王靖宇,常宝成.高尿酸血症/痛风流行病学特点及危险因素[J].国际内分泌代谢杂志,2016,36(02):78-81，88.[doi:10.3760/cma.j.issn.1673-4157.2016.02.002]
　Wang Jingyu,Chang Baocheng..Epidemiological characteristics and risk factors of hyperuricemia/gout[J].International Journal of Endocrinology and Metabolism,2016,36(02):78-81，88.[doi:10.3760/cma.j.issn.1673-4157.2016.02.002]
点击复制

高尿酸血症/痛风流行病学特点及危险因素()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
36
期数:
2016年02期
页码:
78-81，88
栏目:
高尿酸血症/痛风相关代谢性疾病专栏
出版日期:
2016-03-20

文章信息/Info

Title:
Epidemiological characteristics and risk factors of hyperuricemia/gout
作者:
王靖宇; 常宝成
300070 天津医科大学代谢病医院糖尿病肾病科,天津医科大学代谢病医院内分泌研究所,卫生部激素与发育重点实验室, 天津市代谢性疾病重点实验室
Author(s):
Wang Jingyu;  Chang Baocheng.
Department of Diabetic Nephropathy, Key Laboratory of Hormones and Development(Ministry of Health), Tianjin Key Laboratory of Metabolic Diseases, Tianjin Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, 300
关键词:
高尿酸血症;  痛风;  流行病学;  危险因素
Keywords:
Hyperuricemia;  Gout;  Epidemiology;  Risk factor
DOI:
10.3760/cma.j.issn.1673-4157.2016.02.002
摘要:
高尿酸血症/痛风的患病率逐年攀升,呈现高流行、年轻化、男性高于女性、沿海高于内地的流行趋势。肥胖、高血压、高血脂、高血糖等与高尿酸血症/痛风的发生、发展密切相关。小剂量阿司匹林、袢利尿剂和噻嗪类利尿剂等药物亦可促进血清尿酸水平的升高。高尿酸血症是2型糖尿病、高血压、动脉粥样硬化、心血管事件、脑卒中和慢性肾脏病等疾病的独立危险因素,是痛风发作的最主要生化基础和最直接病因。对于高尿酸血症/痛风患者,应强调早期发现和早期治疗。
Abstract:
The morbidity of hyperuricemia/gout increases gradually, which is characterized as hyperendemic, younger in age, higher male morbidity and higher morbidity in coastal areas. Obesity, hypertention, hyperlipidemia and hyperglycemia are closely related to the development and progression of hyperuricemia/gout. Low dose of aspirin, loop diuretics and thiazide diuretics all contribute to the increase of serum uric acid. Hyperuricemia is an independent risk factor for type 2 diabetes, hypertention, atherosclerosis, cardiovascular events, cerebral stroke and chronic kidney disease. Hyperuricemia is also the major biochemical basis and direct cause of gout attack. So the importance of early detection and early treatment should be emphasized for hyperuricemia/gout patients.

参考文献/References:

[1] Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008[J]. Arthritis Rheum,2011,63(10):3136-3141.DOI:10.1002/art.30520.
[2] Trifirò G, Morabito P, Cavagna L, et al. Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study[J]. Ann Rheum Dis, 2013, 72(5):694-700.DOI:10.1136/annrheumdis-2011-201254.
[3] 胡大一,丁荣晶. 无症状高尿酸血症合并心血管疾病诊治建议中国专家共识[J]. 心脑血管病防治, 2010, 10(4): 253-256.DOI: 10.3969/j.issn.1008-1089.2011.02.028.
[4] Juraschek SP, Miller ER 3rd, Gelber AC. Body mass index, obesity, and prevalent gout in the United States in 1988-1994 and 2007-2010[J]. Arthritis Care Res(Hoboken), 2013, 65(1):127-132. DOI: 10.1002/acr.21791.
[5] Kuo CF, Grainge MJ, Mallen C, et al. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study[J]. Ann Rheum Dis, 2015, 74(4):661-667. DOI: 10.1136/annrheumdis-2013-204463.
[6] 路杰, 崔凌凌, 李长贵. 原发性痛风流行病学研究进展[J]. 中华内科杂志, 2015, 54(3): 244-247. DOI: 10.3760/cma.j.issn.0578-1426.2015.03.020
[7] Kuo CF, Grainge MJ, Zhang W, et al. Global epidemiology of gout: prevalence, incidence and risk factors[J]. Nat Rev Rheumatol, 2015, 11(11):649-662. DOI: 10.1038/nrrheum.2015.91.
[8] Liu H, Zhang XM, Wang YL, et al. Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling[J]J Nephrol,2014,[Epub ahead of print].
[9] Tu FY, Lin GT, Lee SS,et al. Prevalence of gout with comorbidity aggregations in southern Taiwan[J].2015,82(1):45-51. DOI: 10.1016/j.jbspin.2014.07.002.
[10] Maynard JW, McAdams-DeMarco MA, Law A, et al. Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study[J]. Am J Epidemiol, 2014, 179(5):576-583.DOI:10.1007/s40620-014-0082-z.
[11] 毛玉山,周丽诺,叶红英,等. 宁波市某石化企业员工高尿酸血症和痛风患病率调查[J]. 中华内分泌代谢杂志, 2006, 22(4): 338-341. DOI: 10.3760/j.issn:1000-6699.2006.04.011.
[12] Aune D, Norat T, Vatten LJ. Body mass index and the risk of gout: a systematic review and dose-response meta-analysis of prospective studies[J]. Eur J Nutr, 2014, 53(8):1591-1601. DOI: 10.1007/s00394-014-0766-0.
[13] Choi HK, Atkinson K, Karlson EW, et al. Alcohol intake and risk of incident gout in men: a prospective study[J]. Lancet,2004,363(9417):1277-1281. DOI: http://dx.doi.org/10.1016/S0140-6736(04)16000-5.
[14] Li C, Hsieh MC, Chang SJ. Metabolic syndrome, diabetes, and hyperuricemia[J]. Curr Opin Rheumatol, 2013, 25(2):210-216. DOI: 10.1097/BOR.0b013e32835d951e.
[15] 王占成,阮长武,姬文慧,等. 无症状高尿酸血症与高血压关系的研究[J].医学综述,2013,19(23):4367-4369. DOI: 10.3969/j.issn.1006-2084.2013.23.050.
[16] McAdams-DeMarco MA, Maynard JW, Baer AN, et al. Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort[J]. J Clin Hypertens(Greenwich), 2012, 14(10):675-679. DOI: 10.1111/j.1751-7176.2012.00674.x.
[17] Katsiki N, Papanas N, Fonseca VA, et al. Uric acid and diabetes: is there a link?[J]. Curr Pharm Des, 2013, 19(27):4930-4937. DOI: 10.2174/1381612811319270016.
[18] Choi HK, Ford ES. Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels--the Third National Health and Nutrition Examination Survey[J]. Rheumatology(Oxford), 2008, 47(5):713-717. DOI: 10.1093/rheumatology/ken066.
[19] Rodríguez G, Soriano LC, Choi HK. Impact of diabetes against the future risk of developing gout[J]. Ann Rheum Dis,2010,69(12):2090-2094.DOI:10.1136/ard.2010.130013.
[20] Borges RL, Ribeiro AB, Zanella MT, et al. Uric acid as a factor in the metabolic syndrome[J].Curr Hypertens Rep,2010,12(2):113-119. DOI: 10.1007/s11906-010-0098-2.
[21] Doshi M, Takiue Y, Saito H, et al. The increased protein level of URAT1 was observed in obesity/metabolic syndrome model mice[J].Nucleosides Nucleotides Nucleic Acids,2011,30(12):1290-1294. DOI: 10.1080/15257770.2011.603711.
[22] Bicker C, Rupprecht HJ, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease[J].Am J Cardiol, 2002, 89(1):12-17.DOI: http://dx.doi.org/10.1016/S0002-9149(01)02155-5.
[23] Chen JH, Pan WH, Hsu CC, et al. Impact of obesity and hypertriglyceridemia on gout development with or without hyperuricemia: a prospective study[J].Arthritis Care Res(Hoboken),2013, 65(1):133-140.DOI:10.1002/acr.21824.
[24] Krishnan E. Chronic kidney disease and the risk of incident gout among middle-aged men: a seven-year prospective observational study[J].Arthritis Rheum, 2013, 65(12):3271-3278.DOI:10.1002/art.38171.
[25] Bruderer S, Bodmer M, Jick SS, et al. Use of diuretics and risk of incident gout: a population-based case-control study[J]. Arthritis Rheumatol,2014,66(1):185-196.DOI: 10.1002/art.38203.
[26] Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008[J]. Am J Med, 2012, 125(7):679-687. DOI: 10.1016/j.amjmed.2011.09.033.
[27] Joo K, Kwon SR, Lim MJ, et al. Prevention of comorbidity and acute attack of gout by uric acid lowering therapy[J]. J Korean Med Sci, 2014, 29(5):657-661.DOI: 10.3346/jkms.2014.29.5.657.
[28] Kodama S, Saito K, Yachi Y, et al. Association between serum uric acid and development of type 2 diabetes[J]. Diabetes Care,2009,32(9):1737-1742.DOI:10.2337/dc09-0288.
[29] Grayson PC, Kim SY, LaValley M, et al. Hyperuricemia and incident hypertension: a systematic review and meta-analysis[J]. Arthritis Care Res(Hoboken), 2011, 63(1):102-110. DOI: 10.1002/acr.20344.
[30] Ofori SN, Odia OJ. Serum uric acid and target organ damage in essential hypertension[J].Vasc Health Risk Manag,2014,10:253-261. DOI: 10.2147/VHRM.S61363.
[31] Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis[J]. Arthritis Care Res(Hoboken), 2010, 62(2):170-180. DOI:10.1002/acr.20065.

相似文献/References:

[1]黄江燕,董力,邹贵勉,等.广西城市社区居民高尿酸血症流行病学调查[J].国际内分泌代谢杂志,2014,(01):5.[doi:10.3760/cma.j.issn.1673-4157.2014.01.002]
　Huang Jiangyan*,Dong Li,Zou Guimian,et al.Epidemiological survey of hyperuricemia in the Guangxi urban community residents[J].International Journal of Endocrinology and Metabolism,2014,(02):5.[doi:10.3760/cma.j.issn.1673-4157.2014.01.002]
[2]聂秀玲,李明珍,孙丽荣.高尿酸血症与非酒精性脂肪性肝病[J].国际内分泌代谢杂志,2016,36(02):89.[doi:10.3760/cma.j.issn.1673-4157.2016.02.004]
　Nie Xiuling,Li Mingzhen,Sun Lirong..Hyperuricemia and non-alcoholic fatty liver[J].International Journal of Endocrinology and Metabolism,2016,36(02):89.[doi:10.3760/cma.j.issn.1673-4157.2016.02.004]
[3]李明珍,聂秀玲,孙丽荣.高尿酸血症与糖代谢异常的关系[J].国际内分泌代谢杂志,2016,36(04):217.[doi:10.3760/cma.j.issn.1673-4157.2016.04.01]
　Li Mingzhen,Nie Xiuling,Sun Lirong.Relationship between hyperuricemia and abnormalities of glucose metabolism[J].International Journal of Endocrinology and Metabolism,2016,36(02):217.[doi:10.3760/cma.j.issn.1673-4157.2016.04.01]
[4]刘彤,杨亚娟.高尿酸血症与心房颤动的关系[J].国际内分泌代谢杂志,2016,36(04):220.[doi:10.3760/cma.j.issn.1673-4157.2016.04.02]
　Liu Tong,Yang Yajuan.Relationship between hyperuricemia and atrial fibrillation[J].International Journal of Endocrinology and Metabolism,2016,36(02):220.[doi:10.3760/cma.j.issn.1673-4157.2016.04.02]
[5]李树颖,孙丽荣.膳食营养与高尿酸血症和痛风的关系[J].国际内分泌代谢杂志,2016,36(04):223.[doi:10.3760/cma.j.issn.1673-4157.2016.04.03]
　Li Shuying,Sun Lirong.Relationship between dietary nutrients and hyperuricemia and gout[J].International Journal of Endocrinology and Metabolism,2016,36(02):223.[doi:10.3760/cma.j.issn.1673-4157.2016.04.03]
[6]刘华英,顾丹阳,邵加庆.高尿酸血症与内皮功能障碍[J].国际内分泌代谢杂志,2016,36(06):412.[doi:10.3760/cma.j.issn.1673-4157.2016.06.14]
　Liu Huaying,Gu Danyang,Shao Jiaqing..Hyperuricemia and endothelial dysfunction[J].International Journal of Endocrinology and Metabolism,2016,36(02):412.[doi:10.3760/cma.j.issn.1673-4157.2016.06.14]
[7]曹雯,孙洪平,褚晓秋,等.生活方式干预与高尿酸血症[J].国际内分泌代谢杂志,2017,37(03):172.[doi:10.3760/cma.j.issn.1673-4157.2017.03.007]
　Cao Wen,Sun Hongping,Chu Xiaoqiu,et al.Lifestyle intervention and hyperuricemia[J].International Journal of Endocrinology and Metabolism,2017,37(02):172.[doi:10.3760/cma.j.issn.1673-4157.2017.03.007]
[8]文钟,童晓霞,谢文光,等.三磷酸腺苷结合盒转运蛋白G2与痛风/高尿酸血症[J].国际内分泌代谢杂志,2017,37(06):422.
　Wen Zhong*,Tong Xiaoxia,Xie Wenguang,et al.ATP-binding cassette sub-family G member 2 and gout/hyperuricemia[J].International Journal of Endocrinology and Metabolism,2017,37(02):422.
[9]冯露文,成志锋.尿酸转运蛋白及其相互作用蛋白在尿酸代谢中的作用研究进展[J].国际内分泌代谢杂志,2021,41(03):220.[doi:10.3760/cma.j.cn121383-20200608-06017]
　Feng Luwen,Cheng Zhifeng..Research progress on the role of uric transporters and its protein interaction in uric acid metabolism[J].International Journal of Endocrinology and Metabolism,2021,41(02):220.[doi:10.3760/cma.j.cn121383-20200608-06017]
[10]牛紫如,陆强.高尿酸血症与不良妊娠结局[J].国际内分泌代谢杂志,2022,42(02):142.[doi:10.3760/cma.j.cn121383-20201114-11029]
　Niu Ziru,Lu Qiang..Hyperuricemia and adverse pregnancy outcomes[J].International Journal of Endocrinology and Metabolism,2022,42(02):142.[doi:10.3760/cma.j.cn121383-20201114-11029]

更新日期/Last Update: 2016-03-20